Intranasal insulin therapy: The clinical realities;KLINISKE KONSEKVENSER AF INTRANASAL INSULINBEHANDLING VED INSULINKRAEVENDE DIABETES MELLITUS

Ugeskrift for Laeger

Volumn 158, Issue 24, 1996, Pages 3451-3455

  Hilsted, Jannik C ^a   Madsbad, Sten ^a   Rasmussen, Michael Højby ^a   Hvidberg, Annemarie ^a   Krarup, Thure ^a   Ipsen, Hanne ^a   Hansen, Bjarne ^a   Pedersen, Mogens ^a   Djurup, Rene ^a   Oxenbøll, Birgitte ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NEUTRAL INSULIN;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE MUCOSA; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; BIOLOGICAL AVAILABILITY; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED;

EID: 8944245846     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wang PH. Tight glucose control and diabetic complications. Lancet 1993; 342: 129.
2. Schade DS, Santiago JV, Skyler JS. Rizza RA. Intensive insulin therapy. Amsterdam: Medical Examination Publishing, 1983.
3. Berger M. Chepper HJ, Chantelau EA, Sonnenberg GE, Joergens V. Absorption kinetics of subcutaneously injected insulin preparations. I: Skyler JS, ed. Insulin update. Amsterdam: Excerpta Medica, 1982: 97-110.
4. Dreyer K, Vaag A, Bech K, Hansen P, Sørensen AR, Mygind N. Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabetic Med 1992; 9: 335-40.
5. Pontiroli AE, Alberetto M, Secchi A, Dossi G, Bosi I, Pozza G. Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. BMJ 1982; 303-6.
6. Moses AC, Gordon GS, Carey MC, Flier JS. Insulin administered intranasally as insulin-bile salt aerosol: effectiveness and reproducibility in normal and diabetic subjects. Diabetes 1983; 32: 1040-7.
7. Saltzman R, Mannson JE, Griffing GT, Kimmerle R, Ruderman N, McCall A et al. Intranasal aerosolized insulin: mixed-meal studies and long term use in type 1 diabetes. N Engl J Med 1985; 312: 1078-84.
8. Frauman AG, Cooper ME, Parsons BJ, Jerums G, Louis WJ. Long term use of intranasal insulin in insulin-dependent diabetic patients. Diabetes Care 1987; 10: 573-8.
9. Frauman AG, Jerums G, Louis WJ. Effects of intranasal insulin in non-obese type 2 diabetes. Diabetes Res Clin Pract 1987; 3: 197-202.
10. Moriarty BG, Robson AM, Smallman LA, Drake-Lee AB. Nasal mucociliary function: comparison of saccharin clearance with ciliary beat frequency. Rhinology 1991; 29: 173-9.
11. Pedersen M, Sakakura Y, Winther B, Brofeldt S, Mygind N. Nasal mucociliary transport, number of ciliated cells, and beating pattern in naturally acquired common cold. Eur J Respir Dis 1983; 128 (suppl): 355-64.
12. Hansen BJ, Osterhammel PA. Morphometrical evaluations of nosecasts compared to acoustic rhinometry. J Jpn Rhinol Soc 1991; 30: 124.
13. Andersen L, Dinesen B, Jørgensen PN. Poulsen F, Røder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578-82.
14. Armitage P. Statistical methods in medical research. Oxford: Blackwell, 1971: 189-217.
15. El-Etr M, Slama G, Desplanque N. Preprandial intranasal insulin as adjuvant therapy in type 2 diabetics. Lancet 1987; II: 1085-6.